# Societal Cdmo San Diego, LLC

Canonical: https://abierto.us/vendors/societal-cdmo-san-diego-llc-yrptvkhdl7z5

- UEI: YRPTVKHDL7Z5
- CAGE: 7B0Z1
- Parent: Recro Pharma, Inc.
- Location: San Diego, CA
- Awards in window: 6 (6 transactions), -$12,304 obligated, April 29, 2025 to August 6, 2026

## Awarding agencies

- National Institutes of Health: 6 awards, -$12,304

## Industries

- 325412 Pharmaceutical Preparation Manufacturing: -$12,304

## Competition

- Full and Open Competition: 5 awards
- Competed Under SAP: 1 awards

## Largest awards

- 75N95021F00002 (delivery order): $0, National Institutes of Health Nida. Eoi::implementing the Presidents Department of Government Efficiency Cost Efficiency Initiative (March 19, 2025)::EOI Notice of Partial Termination for Convenience Dosage Form Development, Manufacture, and Stability Studies of R-VK4-116. https://www.usaspending.gov/award/CONT_AWD_75N95021F00002_7529_HHSN271201700020I_7529/
- 75N95021F00003 (delivery order): $0, National Institutes of Health Nida. Eoi::implementing the Presidents Department of Government Efficiency Cost Efficiency Initiative (March 19, 2025)::EOI Notice of Termination for Convenience Dosage Form Development, Manufacture, and Stability Studies of NES-100 Nasal Spray. https://www.usaspending.gov/award/CONT_AWD_75N95021F00003_7529_HHSN271201700020I_7529/
- 75N95022F00001 (delivery order): $0, National Institutes of Health Nida. Eoi:: Implementing the Presidents Department of Government Efficiency Cost Efficiency Initiative (March 19, 2025)::EOI Notice of Termination for Convenience This Task Order (To) Is to Provide Dosage Form Development, Manufacture and Stability Studie. https://www.usaspending.gov/award/CONT_AWD_75N95022F00001_7529_HHSN271201700020I_7529/
- 75N95023F00001 (delivery order): $0, National Institutes of Health Nida. Eoi::implementing the Presidents Department of Government Efficiency Cost Efficiency Initiative (March 19, 2025)::EOI Notice of Termination for Convenience Dosage Form Development, Manufacture, and Stability Studies of Ncgc72. https://www.usaspending.gov/award/CONT_AWD_75N95023F00001_7529_HHSN271201700020I_7529/
- 75N91020F00005 (delivery order): -$1,304, NIH NCI. FY26 Udo Initiative Production of Various Strength of Ipdr Capsules for Clinical Use; Pop: 05/08/2020 - 05/07/2021. https://www.usaspending.gov/award/CONT_AWD_75N91020F00005_7529_HHSN261201500009I_7529/
- 75N90020P00016 (purchase order): -$11,000, National Institutes of Health - CC. To Administratively De-Obligate Unexpended and Expiring Fiscal Year 2021 Funding in Accordance with 31 U.S.C. Section 1552 (A), in Preparation for September 30, 2026, Closing of the Period of Availability of These Fiscal Year Funds.. https://www.usaspending.gov/award/CONT_AWD_75N90020P00016_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/societal-cdmo-san-diego-llc-yrptvkhdl7z5.